Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,700 public trials 1,041 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

NCT04853017

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Cancer, +57 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

NCT04879849

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
Locations
  • Cedars Sinai Medical Center Duarte, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Laura And Isaac Perlmutter Cancer Center New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View Trial Details
Completed

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

NCT03715205

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Nizam's Institute of Medical Sciences ( Site 0011) Hyderabad, Andhra Pradesh, India
  • Artemis Health Institute ( Site 0007) Gurgaon, Haryana, India
  • Tata Memorial Hospital [M] ( Site 0005) Mumbai, Maharashtra, India
  • Kokilaben Ben Dhirubhai Ambani Hosp & Med Res Inst. ( Site 0001) Mumbai, Maharashtra, India
View Trial Details
Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions
Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations
  • UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
  • Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States
  • Goshen Health System Goshen, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View all 22 locations
View Trial Details
Completed

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

NCT03977467

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Florida Cancer Specialists - South Fort Myers, Florida, United States
  • Florida Cancer Specialists - North St. Petersburg, Florida, United States
  • Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Florida Cancer Specialists - East West Palm Beach, Florida, United States
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)

NCT03322540

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Pacific Cancer Medical Center, Inc. Anaheim, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • Florida Cancer Specialists (South Region) Fort Myers, Florida, United States
  • Florida Cancer Specialists (North Region) St. Petersburg, Florida, United States
View all 101 locations
View Trial Details

Related conditions